A Dopamine D
Journal
The Journal of pharmacology and experimental therapeutics
ISSN: 1521-0103
Titre abrégé: J Pharmacol Exp Ther
Pays: United States
ID NLM: 0376362
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
16
03
2022
accepted:
17
05
2022
pubmed:
7
6
2022
medline:
22
7
2022
entrez:
6
6
2022
Statut:
ppublish
Résumé
Methylphenidate is used widely to treat symptoms of attention-deficit/hyperactivity disorder (ADHD), but like other stimulants has significant side effects. This study used a rodent model (spontaneously hypertensive rat) of spatial working memory (sWM) to compare the effects of methylphenidate with the novel dopamine D
Identifiants
pubmed: 35661631
pii: jpet.122.001215
doi: 10.1124/jpet.122.001215
pmc: PMC9341252
doi:
Substances chimiques
Central Nervous System Stimulants
0
Dopamine Agonists
0
Receptors, Dopamine D1
0
Methylphenidate
207ZZ9QZ49
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
88-99Subventions
Organisme : NINDS NIH HHS
ID : R01 NS105471
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG071675
Pays : United States
Informations de copyright
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics.
Références
Cereb Cortex. 2007 Jun;17(6):1364-75
pubmed: 16920883
Neuropsychopharmacology. 2015 Jan;40(2):446-53
pubmed: 25074637
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):990-1002.e2
pubmed: 23021476
Science. 2007 Mar 30;315(5820):1860-2
pubmed: 17395832
Behav Brain Res. 2018 May 2;343:50-60
pubmed: 29378292
Cell. 2007 Apr 20;129(2):397-410
pubmed: 17448997
Am J Psychiatry. 2007 Nov;164(11):1729-36
pubmed: 17974939
Rev Neurosci. 2011;22(3):365-71
pubmed: 21591908
Nat Rev Drug Discov. 2016 Mar;15(3):145-6
pubmed: 26669674
Curr Top Behav Neurosci. 2012;9:301-15
pubmed: 21487952
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8690-4
pubmed: 8078943
J Pharmacol Exp Ther. 1997 Oct;283(1):183-9
pubmed: 9336323
Schizophr Res. 2007 Aug;94(1-3):332-41
pubmed: 17596915
Pharmacol Biochem Behav. 2011 Aug;99(2):211-6
pubmed: 21295057
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jan;3(1):19-29
pubmed: 29397074
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jun;369(6):576-82
pubmed: 15138661
J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):217-28.e1-3
pubmed: 20410711
JAMA Pediatr. 2017 Feb 1;171(2):181-189
pubmed: 28027344
Am J Psychiatry. 1999 Jun;156(6):891-6
pubmed: 10360128
Mol Psychiatry. 2004 May;9(5):500-9
pubmed: 14569274
J Neurosci. 1997 Nov 1;17(21):8528-35
pubmed: 9334425
J Parkinsons Dis. 2020;10(4):1515-1527
pubmed: 32986682
Biol Psychiatry. 2006 Nov 15;60(10):1111-20
pubmed: 16806100
Pediatrics. 2011 Nov;128(5):1007-22
pubmed: 22003063
Neuropsychopharmacology. 2000 Jan;22(1):4-13
pubmed: 10633485
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2
pubmed: 24342384
Neuroimage. 1997 Jan;5(1):49-62
pubmed: 9038284
Med Hypotheses. 2013 Dec;81(6):988-94
pubmed: 24095262
Brain. 2002 Mar;125(Pt 3):624-39
pubmed: 11872618
Eur Neuropsychopharmacol. 2003 Dec;13(6):459-68
pubmed: 14636962
Expert Rev Neurother. 2019 Jul;19(7):707-717
pubmed: 31167583
Biol Psychiatry. 2015 Jun 1;77(11):940-50
pubmed: 25499957
Neuropsychologia. 1996 Oct;34(10):953-63
pubmed: 8843061
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1011-23
pubmed: 20855046
Neurodegener Dis. 2018;18(5-6):262-269
pubmed: 30453303
Nat Commun. 2018 Feb 14;9(1):674
pubmed: 29445200
Mol Psychiatry. 2021 Feb;26(2):645-655
pubmed: 30532019
Curr Opin Investig Drugs. 2001 Nov;2(11):1582-91
pubmed: 11763161
J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53
pubmed: 18480677
J Neurosci. 2007 Nov 28;27(48):13140-50
pubmed: 18045908
Nat Neurosci. 2006 Feb;9(2):276-82
pubmed: 16429134
J Neurosci. 1996 Dec 1;16(23):7768-75
pubmed: 8922432
Psychopharmacology (Berl). 2010 Jun;210(3):407-18
pubmed: 20401749
Eur Neuropsychopharmacol. 2011 Feb;21(2):192-204
pubmed: 21146374
Clin Pharmacol Ther. 1999 Sep;66(3):295-305
pubmed: 10511066
Science. 2000 Mar 17;287(5460):2020-2
pubmed: 10720329
Psychopharmacology (Berl). 1996 May;125(2):97-104
pubmed: 8783382
Psychopharmacology (Berl). 1999 Mar;143(1):102-10
pubmed: 10227086
Eur J Pharmacol. 1996 Sep 12;311(2-3):103-7
pubmed: 8891588
J Med Chem. 1995 Aug 4;38(16):3062-70
pubmed: 7636869
Biol Psychiatry. 2006 Nov 15;60(10):1071-80
pubmed: 16876137
J Neurosci. 2002 Aug 15;22(16):7264-71
pubmed: 12177221
Biol Psychiatry. 2008 Oct 1;64(7):626-35
pubmed: 18585681
Nature. 2001 Jun 21;411(6840):953-6
pubmed: 11418860
J Neurosci. 2014 Jan 22;34(4):1171-82
pubmed: 24453310
Int J Neuropsychopharmacol. 2009 Aug;12(7):873-83
pubmed: 19154630
Mol Neurobiol. 2012 Jun;45(3):605-20
pubmed: 22610946
Behav Pharmacol. 1995 Dec;6(8):785-793
pubmed: 11224381
Front Pharmacol. 2020 Jul 07;11:1005
pubmed: 32733245
Schizophr Bull. 1982;8(2):236-52
pubmed: 6180471
J Pharmacol Exp Ther. 2007 Jan;320(1):1-13
pubmed: 16803859
Neuron. 1995 Mar;14(3):477-85
pubmed: 7695894
Neuropsychopharmacology. 2006 Mar;31(3):594-601
pubmed: 15999146
Brain Res Bull. 2017 Apr;130:125-137
pubmed: 28111275
Neurol Ther. 2018 Dec;7(2):307-319
pubmed: 30361858
Ann N Y Acad Sci. 2000;909:133-44
pubmed: 10911927
J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171-9
pubmed: 21241954
Neurosci Biobehav Rev. 2011 Aug;35(8):1722-39
pubmed: 21376076
Neuropharmacology. 2019 May 15;150:46-58
pubmed: 30858103
Neuroreport. 1995 Nov 27;6(17):2314-6
pubmed: 8747144
Behav Brain Funct. 2005 Apr 22;1(1):2
pubmed: 15916700
Psychopharmacology (Berl). 1994 Oct;116(2):143-51
pubmed: 7862943
Biol Psychiatry. 2017 Jan 1;81(1):67-77
pubmed: 26946382
Biol Psychiatry. 2015 Dec 15;78(12):860-70
pubmed: 25731884
J Neural Transm (Vienna). 2017 Feb;124(2):159-170
pubmed: 27853928
JAMA Pediatr. 2018 Oct 1;172(10):901-902
pubmed: 30105354
Biol Psychiatry. 2014 Sep 1;76(5):422-9
pubmed: 24120092
J Neurosci Methods. 2004 Mar 15;134(1):9-21
pubmed: 15102499
J Exp Pharmacol. 2015 Apr 20;7:1-9
pubmed: 27186140
Nat Neurosci. 2007 Mar;10(3):376-84
pubmed: 17277774